LightHearted AI develops a laser-based diagnostics device that utilizes advanced AI to detect heart conditions by acquiring biomarkers from a distance. This contactless technology provides rapid and accurate diagnostic reports, making heart disease detection more accessible and affordable.
Funding
$830K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IIFounders
Product
Problem
Traditional methods of heart disease detection often require direct contact, expert intervention, and can be time-consuming and costly, limiting accessibility and efficiency in diagnostics. This can lead to delays in diagnosis and treatment, particularly in underserved communities or remote areas.
Solution
LightHearted AI offers a contactless, laser-based diagnostics platform that uses advanced AI to detect heart conditions by acquiring biomarkers from a distance. The device aims to democratize heart diagnostics by providing rapid and accurate diagnostic reports without the need for expert intervention. The company's precision cardiology platform acquires biomarkers from a distance, enabling quick and efficient heart disease diagnosis.
Target Audience
The primary target audience includes healthcare providers, hospitals, and diagnostic centers seeking to improve the accessibility, speed, and accuracy of heart disease detection, as well as individuals in underserved communities.
Features
- Non-contact diagnostics using laser-based technology
- Advanced AI algorithms for biomarker analysis and heart condition detection
- Rapid and accurate diagnostic reports
- Accessible and efficient diagnostic process